DK578485A - Dihydropyridin-carboxylsyreamider, deres fremstilling og anvendelse i laegemidler - Google Patents
Dihydropyridin-carboxylsyreamider, deres fremstilling og anvendelse i laegemidler Download PDFInfo
- Publication number
- DK578485A DK578485A DK578485A DK578485A DK578485A DK 578485 A DK578485 A DK 578485A DK 578485 A DK578485 A DK 578485A DK 578485 A DK578485 A DK 578485A DK 578485 A DK578485 A DK 578485A
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- carboxylic acid
- acid amides
- medicinal products
- dihydropyridine carboxylic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843445852 DE3445852A1 (de) | 1984-12-15 | 1984-12-15 | Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK578485D0 DK578485D0 (da) | 1985-12-13 |
| DK578485A true DK578485A (da) | 1986-06-16 |
Family
ID=6252899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK578485A DK578485A (da) | 1984-12-15 | 1985-12-13 | Dihydropyridin-carboxylsyreamider, deres fremstilling og anvendelse i laegemidler |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4707479A (da) |
| EP (1) | EP0185964B1 (da) |
| JP (1) | JPH0631224B2 (da) |
| AT (1) | ATE50571T1 (da) |
| AU (1) | AU5107085A (da) |
| CA (1) | CA1259996A (da) |
| DE (2) | DE3445852A1 (da) |
| DK (1) | DK578485A (da) |
| ES (4) | ES8700850A1 (da) |
| HU (1) | HUT40081A (da) |
| ZA (1) | ZA859550B (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN164232B (da) * | 1986-04-11 | 1989-02-04 | Hoechst India | |
| DE3712369A1 (de) * | 1987-04-11 | 1988-10-27 | Bayer Ag | Substituierte 5-nitro-1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung |
| DE3712371A1 (de) * | 1987-04-11 | 1988-10-27 | Bayer Ag | Substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung |
| DE3724909A1 (de) * | 1987-07-28 | 1989-02-09 | Bayer Ag | Neue substituierte nitro-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung |
| GB8804439D0 (en) * | 1988-02-25 | 1988-03-23 | Pfizer Ltd | Dihydropyridines |
| DE3833892A1 (de) * | 1988-10-05 | 1990-04-12 | Bayer Ag | Basische 4-aryl-dhp-amide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| WO1990009377A1 (en) * | 1989-02-17 | 1990-08-23 | Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr | Alcaline salts of 2-(2,6-dimethyl-3,5-diethoxycarbonyl-1,4-dihydropyridine-4-carboxamido) ethane sulphonic acid and method of obtaining them |
| CA2069877A1 (en) * | 1990-10-02 | 1992-04-03 | Michio Nakanishi | Ethynylphenyl derivative substituted by pyridazinone and medicament for circulatory disease containing the same as an effective ingredient |
| US5100892A (en) * | 1990-11-13 | 1992-03-31 | Glaxo Inc. | Dihydropyridine vasodilator agents |
| DE4118707A1 (de) * | 1991-06-07 | 1992-12-10 | Bayer Ag | Pharmazeutische verwendung von 3-formyl-1,4-dihydropyridinen, neue verbindungen und verfahren zu ihrer herstellung |
| DE4202526A1 (de) * | 1992-01-30 | 1993-08-05 | Bayer Ag | Neue 4-cinnolinyl- und 4-naphthyridinyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| EP1252134B1 (de) * | 2000-02-04 | 2004-10-06 | Lonza AG | Verfahren zur herstellung von acetoacetylierten aromatischen aminen |
| CA2501534A1 (en) * | 2002-10-07 | 2004-04-22 | Artesian Therapeutics, Inc. | Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| WO2018086703A1 (en) | 2016-11-11 | 2018-05-17 | Bayer Pharma Aktiengesellschaft | Dihydropyridazinones substituted with phenylureas |
| WO2019149637A1 (en) | 2018-01-31 | 2019-08-08 | Bayer Aktiengesellschaft | Antibody drug conjugates (adcs) with nampt inhibitors |
| WO2021013693A1 (en) | 2019-07-23 | 2021-01-28 | Bayer Pharma Aktiengesellschaft | Antibody drug conjugates (adcs) with nampt inhibitors |
| EP4252843A4 (en) * | 2020-11-30 | 2025-02-19 | Univ Kyushu Nat Univ Corp | COMPOUND HAVING AN INHIBITORY ACTION AGAINST EXCESSIVE MITOCHONDRIAL DIVISIONS |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2752820A1 (de) * | 1977-11-26 | 1979-05-31 | Bayer Ag | Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| US4639451A (en) * | 1981-10-20 | 1987-01-27 | Mitsui Toatsu Kagaku-Kabushiki Kaisha | Pyridazinone derivatives |
| DE3319956A1 (de) * | 1983-06-01 | 1984-12-06 | Bayer Ag, 5090 Leverkusen | 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
-
1984
- 1984-12-15 DE DE19843445852 patent/DE3445852A1/de not_active Withdrawn
-
1985
- 1985-11-30 EP EP85115209A patent/EP0185964B1/de not_active Expired - Lifetime
- 1985-11-30 DE DE8585115209T patent/DE3576156D1/de not_active Expired - Lifetime
- 1985-11-30 AT AT85115209T patent/ATE50571T1/de not_active IP Right Cessation
- 1985-12-05 US US06/806,057 patent/US4707479A/en not_active Expired - Fee Related
- 1985-12-10 AU AU51070/85A patent/AU5107085A/en not_active Abandoned
- 1985-12-12 ES ES549873A patent/ES8700850A1/es not_active Expired
- 1985-12-13 HU HU854781A patent/HUT40081A/hu unknown
- 1985-12-13 DK DK578485A patent/DK578485A/da not_active Application Discontinuation
- 1985-12-13 CA CA000497582A patent/CA1259996A/en not_active Expired
- 1985-12-13 JP JP60279387A patent/JPH0631224B2/ja not_active Expired - Lifetime
- 1985-12-13 ZA ZA859550A patent/ZA859550B/xx unknown
-
1986
- 1986-08-01 ES ES556987A patent/ES8707501A1/es not_active Expired
- 1986-08-01 ES ES556988A patent/ES8801208A1/es not_active Expired
- 1986-08-01 ES ES556986A patent/ES8801207A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE3576156D1 (de) | 1990-04-05 |
| ES556987A0 (es) | 1987-08-01 |
| EP0185964A3 (en) | 1986-12-03 |
| JPS61145180A (ja) | 1986-07-02 |
| EP0185964B1 (de) | 1990-02-28 |
| DE3445852A1 (de) | 1986-06-19 |
| ES8707501A1 (es) | 1987-08-01 |
| US4707479A (en) | 1987-11-17 |
| ES8801208A1 (es) | 1987-12-16 |
| ATE50571T1 (de) | 1990-03-15 |
| ES549873A0 (es) | 1986-11-16 |
| HUT40081A (en) | 1986-11-28 |
| JPH0631224B2 (ja) | 1994-04-27 |
| AU5107085A (en) | 1986-06-19 |
| ES556988A0 (es) | 1987-12-16 |
| EP0185964A2 (de) | 1986-07-02 |
| CA1259996A (en) | 1989-09-26 |
| ES8801207A1 (es) | 1987-12-16 |
| ZA859550B (en) | 1986-08-27 |
| ES8700850A1 (es) | 1986-11-16 |
| DK578485D0 (da) | 1985-12-13 |
| ES556986A0 (es) | 1987-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK578485D0 (da) | Dihydropyridin-carboxylsyreamider, deres fremstilling og anvendelse i laegemidler | |
| MY103352A (en) | Piperazinyl-heterocyclic compounds | |
| ATE90573T1 (de) | Verfahren zum stabilisieren von menschlichen albuminloesungen und so erhaltene loesung. | |
| MC2078A1 (fr) | Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires | |
| NO820686L (no) | Fremgangsmaate ved fremstilling av nye aroylimidazoloner | |
| ATE91625T1 (de) | Verwendung von porphyrinderivaten bei der entdeckung und behandlung von tumoren. | |
| MY103210A (en) | Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds. | |
| NO810480L (no) | Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater | |
| DE59108997D1 (de) | Chromanderivate | |
| IT1230140B (it) | Derivati della serina, loro processo di preparazione e impiego in terapia umana | |
| HUT48464A (en) | Process for producing pharmaceutical composition for treating hypertonia and cardiac failure | |
| ZA806282B (en) | Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters,their preparation,and pharmaceutical formulations containing these compounds | |
| FR2530246B1 (fr) | Nouveaux derives pyrido indoliniques et pirido indoliques et leurs sels, ainsi que le procede de preparation et l'application en therapeutique de ces derives et sels | |
| DK455185A (da) | Pyridinderivater | |
| ATE4808T1 (de) | Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| FR2530236B1 (fr) | Nouveaux derives aminoalkyl naphtaleniques, leurs sels d'addition d'acide et le procede de preparation ainsi que l'application en therapeutique de ces derives et sels | |
| FR2470111B1 (fr) | Derives de la decaprenylamine, leurs sels acides d'addition et composition pharmaceutique utilisant ces produits | |
| BR8601204A (pt) | Estimulador termico da circulacao sanguinea facial | |
| IT7945204A0 (it) | Composizione farmaceutica per la terapia delle sterilita' maschile |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ATS | Application withdrawn |